Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Novel therapeutic agents for cancer covered in recent patents

June 25, 2007

DeveloGen grants worldwide exclusive license to Teva for protein kinase B

June 22, 2007

Interim findings for AVN-944 in hematologic malignancies

June 22, 2007

OSI Pharmaceuticals begins phase I trials of OSI-906 for tumors

June 22, 2007

Phase III ENRICH study of Efaproxyn fails to meet primary and secondary endpoints

June 21, 2007

AZD-2281 begins phase II trials for breast and ovarian cancers

June 21, 2007

Canadian approval for Eloxatin in metastatic colorectal cancer

June 21, 2007

Enrollment completed in phase III trial of Yondelis for relapsed ovarian cancer

June 21, 2007

Vegenics licenses antibodies against VEGF-C from CoGenesys

June 21, 2007

Nexavar submitted in E.U. for hepatocellular carcinoma

June 20, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...